Adenotonsillar disease

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 6, Issue 2, 2012, Pages 121-129

  Zautner, Andreas E ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Adenoiditis; Mucosal biofilm; Recurrent tonsillitis; Staphylococcus aureus

Indexed keywords

AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CHLOROPHYLITE; CLARITHROMYCIN; CLAVULANIC ACID; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; IMMUNOSTIMULATING AGENT; IMUDON; MACROLIDE; METHYLENE BLUE; METRONIDAZOLE; ORITAVANCIN; PENICILLIN G; PENICILLIN V; PHOTOSENSITIZING AGENT; PORPHYRIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADENOIDECTOMY; ADENOIDITIS; ADENOTONSILLAR DISEASE; ADENOTONSILLAR HYPERTROPHY; ANTIBIOTIC SENSITIVITY; ANTIBODY TITER; BIOFILM; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CHRONIC TONSILLITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIET THERAPY; DYSPHAGIA; HAEMOPHILUS; HALITOSIS; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; LASER SURGERY; LEMIERRE SYNDROME; MOUTH HYGIENE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PATHOGENESIS; PERITONSILLAR ABSCESS; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; RECURRENT TONSILLITIS; REVIEW; SENSITIVITY AND SPECIFICITY; SLEEP APNEA SYNDROME; SNORING; SORE THROAT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TONSIL DISEASE; TONSILLECTOMY; TONSILLITIS; UPPER RESPIRATORY TRACT OBSTRUCTION;

ADENOIDS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BIOFILMS; HUMANS; HYPERTROPHY; PATENTS AS TOPIC; TONSILLITIS;

EID: 84860273426     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221312800166877     Document Type: Review

References (136)

1. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: From the natural environment to infectious diseases. Nat Rev Microbiol 2004; 2(2): 95-108.
2. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol 2009; 11(7):1034-1043.
3. Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg 2004; 12(3): 185-190.
4. von Waldeyer-Hartz HWG. Über den lymphatischen Apparat des Pharynx. Dtsch Med Wochenschr 1884; 10: 313.
5. Brown MR, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: A growth-rate related effect? J Antimicrob Che-mother 1988; 22(6): 777-780.
6. Anwar H, Strap JL, Costerton JW. Establishment of aging biofilms: Possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother 1992; 36(7): 1347-1351.
7. Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003; 47(1): 317-323.
8. [Hall-Stoodley L, Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol 2005; 13(1): 7-10. Erratum in: Trends Microbiol 2005; 13(7): 300-301.
9. Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol 2010; 8(9): 623-633.
10. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995; 49: 711-745.
11. Waters CM, Bassler BL. Quorum sensing: cell-to-cell communica tion in bacteria. Annu Rev Cell Dev Biol 2005; 21:319-346.
12. Dickschat JS. Quorum sensing and bacterial biofilms. Nat Prod Rep 2010; 27(3): 343-369.
13. Sun J, Daniel R, Wagner-Döbler I, Zeng AP. Is autoinducer-2 a universal signal for interspecies communication: A comparative genomic and phylogenetic analysis of the synthesis and signal transduction pathways. BMC Evol Biol 2004; 4: 36.
14. Hausner M, Wuertz S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol 1999; 65(8): 3710-3713.
15. Marsh PD. Plaque as a biofilm: Pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Dis 2003; 9(Suppl 1):16-22.
16. Marrie TJ, Nelligan J, Costerton JW. A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 1982; 66(6): 1339-1341.
17. Fowler VG Jr, Li J, Corey GR, Boley J, Marr KA, Gopal AK, et al. Role of echocardiography in evaluation of patients with Staphylo-coccus aureus bacteremia: Experience in 103 patients. J Am Coll Cardiol 1997; 30(4): 1072-1078.
18. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339(8): 520-532.
19. Fux CA, Wilson S, Stoodley P. Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model. J Bacteriol 2004; 186(14): 4486-4491.
20. Fux CA, Stoodley P, Hall-Stoodley L, Costerton JW. Bacterial biofilms: A diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 2003; 1(4): 667-683.
21. Parsek MR, Singh PK. Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
22. Chole RA, Faddis BT. Anatomical evidence of microbial biofilms in tonsillar tissues: A possible mechanism to explain chronicity. Arch Otolaryngol Head Neck Surg 2003; 129(6): 634-636.
23. Stoodley P, Debeer D, Longwell M, Nistico L, Hall-Stoodley L, Wenig B, et al. Tonsillolith: Not just a stone but a living biofilm. Otolaryngol Head Neck Surg 2009; 141(3): 316-621.
24. Hoa M, Tomovic S, Nistico L, Hall-Stoodley L, Stoodley P, Sachdeva L, et al. Identification of adenoid biofilms with middle ear pathogens in otitis-prone children utilizing SEM and FISH. Int J Pediatr Otorhinolaryngol 2009; 73(9): 1242-1248.
25. Nistico L, Kreft R, Gieseke A, Coticchia JM, Burrows A, Kham-pang P, et al. Adenoid reservoir for pathogenic biofilm bacteria. J Clin Microbiol 2011; 49(4): 1411-1420.
26. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L. Nguyen D, Hayes J, et al. Direct detection of bacterial biofilms on the middle-ear mu-cosa of children with chronic otitis media. JAMA 2006; 296(2): 202-211.
27. Park K. Otitis media and tonsils--role of adenoidectomy in the treatment of chronic otitis media with effusion. Adv Otorhino-laryngol 2011; 72: 160-163.
28. Brietzke SE, Brigger MT. Adenoidectomy outcomes in pediatric rhinosinusitis: A meta-analysis. Int J Pediatr Otorhinolaryngol 2008; 72(10): 1541-1545.
29. Rayner MG, Zhang Y, Gorry MC, Chen Y, Post JC, Ehrlich GD. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 1998; 27984): 296-299.
30. Kiroglu F, Kaya M, Ozsahinoglu C, Soylu L, Polat S. Changes of middle ear mucosa in secretory otitis media treated with ventilation tubes. Acta Otolaryngol 1990; 110(3-4): 266-273.
31. Chole RA, Faddis BT. Evidence for microbial biofilms in cho-lesteatomas. Arch Otolaryngol Head Neck Surg 2002; 128(10): 1129-1133.
32. Krespi YP, Shrime MG, Kacker A. The relationship between oral malodor and volatile sulfur compound-producing bacteria. Oto-laryngol Head Neck Surg 2006; 135(5): 671-676.
33. Tsuneishi M, Yamamoto T, Kokeguchi S, Tamaki N, Fukui K, Watanabe T. Composition of the bacterial flora in tonsilloliths. Microbes Infect 2006; 8(9-10): 2384-2389.
34. Podbielski A, Beckert S, Schattke R, Leithäuser F, Lestin F, Gossler B, et al. Epidemiology and virulence gene expression of in-tracellular group A streptococci in tonsils of recurrently infected adults. Int J Med Microbiol 2003; 293(2-3): 179-190.
35. Zautner AE, Krause M, Stropahl G, Holtfreter S, Frickmann H, Maletzki C, et al. Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS One 2010; 5(3): e9452.
36. Szuhay G, Tewfik TL. Peritonsillar abscess or cellulitis? A clinical comparative paediatric study. J Otolaryngol 1998; 27(4): 206-212.
37. Schraff S, McGinn JD, Derkay CS. Peritonsillar abscess in children: A 10-year review of diagnosis and management. Int J Pediatr Otorhinolaryngol 2001; 57(3): 213-218.
38. Cherukuri S, Benninger MS. Use of bacteriologic studies in the outpatient management of peritonsillar abscess. Laryngoscope 2002; 112(1): 18-20.
39. Brook I. Microbiology and management of peritonsillar, retro-pharyngeal, and parapharyngeal abscesses. J Oral Maxillofac Surg 2004; 62(12): 1545-1550.
40. Brook I. The role of anaerobic bacteria in tonsillitis. Int J Pediatr Otorhinolaryngol 2005; 69(1): 9-19.
41. Gavriel H, Vaiman M, Kessler A, Eviater E. Microbiology of peri-tonsillar abscess as an indication for tonsillectomy. Medicine 2008; 87(1): 33-36.
42. Brook I. Microbiology and management of deep facial infections and Lemierre syndrome. ORL J Otorhinolaryngol Relat Spec 2003; 65(2): 117-120.
43. Maier W, Lohnstein PU, Schipper J, Boedeker C. Jugular vein thrombosis and Lemierre's syndrome -- severe complications of oropharyngeal infections. Laryngorhinootologie 2010; 89(9): 533-538.
44. Syed MI, Baring D, Addidle M, Murray C, Adams C. Lemierre syndrome: Two cases and a review. Laryngoscope 2007; 117(9): 1605-1610.
45. Lemierre A. On certain septicemias due to anaerobic organisms. Lancet 1936; 1: 701-703.
46. Schottmuller H. Ueber die Pathogenität anaërober Bazillen. Dtsch Med Wochenschr 1918; 44: 1440.
47. Beldman TF, Teunisse HA, Schouten TJ. Septic arthritis of the hip by Fusobacterium necrophorum after tonsillectomy: A form of Lemierre syndrome?. Eur J Pediatr 1997; 156(11): 856-857.
48. Screaton NJ, Ravenel JG, Lehner PJ, Heitzman ER, Flower CD. Lemierre Syndrome: Forgotten but not extinct-report of four cases. Radiology 1999; 213(2): 369-374.
49. Chirinos JA, Lichtstein DM, Garcia J, Tamariz LJ. The evolution of Lemierre syndrome: Report of 2 cases and review of the literature. Medicine 2002; 81(6): 458-465.
50. Hagelskjaer Kristensen L, Prag J. Human necrobacillosis, with emphasis on Lemierre's syndrome. Clin Infect Dis 2000; 3182: 524-532.
51. th ed. Philadelphia: Saunders 2007: 1756-1757.
52. Zautner AE, Krause M, Stropahl G, Podbielski A. Recurrent tonsil-lopharyngitis associated with Burkholderia cenocepacia: Two case report. HNO 2009; 5785: 515-518.
53. Swidsinski A, Göktas O, Bessler C, Loening-Baucke V, Hale LP, Andree H, et al. Spatial organisation of microbiota in quiescent adenoiditis and tonsillitis. J Clin Pathol 2007; 60(3): 253-260.
54. Olofsson K, Hellström S, Hammarström ML. The surface epithelium of recurrent infected palatine tonsils is rich in gammadelta T cells. Clin Exp Immunol 1998; 111(1): 36-47.
55. Brodsky L, Moore L, Stanievich JF, Ogra PL. The immunology of tonsils in children: The effect of bacterial load on the presence of B- and T-cell subsets. Laryngoscope 1988; 98(1): 93-98.
56. Papadas T, Batistatou A, Ravazoula P, Zolota V. Goumas P. S-100 protein-positive dendritic cells and CD34-positive dendritic interstitial cells in palatine tonsils. Eur Arch Otorhinolaryngol 2001; 258(5): 243-245.
57. Alatas N, Baba F. Proliferating active cells, lymphocyte subsets, and dendritic cells in recurrent tonsillitis: Their effect on hypertrophy. Arch Otolaryngol Head Neck Surg 2008; 134(5): 477-483.
58. Shanker S, Vig KW, Beck FM, Allgair E Jr, Vig PS. Dentofacial morphology and upper respiratory function in 8-10-year-old children. Clin Orthod Res 1999; 2(1): 19-26.
59. Koch RJ, Brodsky L. Qualitative and quantitative immunoglobulin production by specific bacteria in chronic tonsillar disease. Laryngoscope 1995; 10581): 42-48.
60. Passàli D, Damiani V, Passàli GC, Passàli FM, Boccazzi A, Bel-lussi L. Structural and immunological characteristics of chronically inflamed adenotonsillar tissue in childhood. Clin Diagn Lab Immunol 2004; 11(6): 1154-1157.
61. Kasenõmm P, Piirsoo A, Kull M, Kull M Jr, Mikelsaar M. Selection of indicators for tonsillectomy in adults with recurrent tonsillitis. BMC Ear Nose Throat Disord 2005; 5: 7.
62. [Österreichische Gesellschaft für Hals-Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie. Gemeinsame Empfehlung der Öster-reichischen Gesellschaften für Hals-Nasen-Ohren-Heilkunde, Kopf- und Halschirurgie und Kinder- und Jugendheilkunde zur Entfernung der Gaumenmandeln (Tonsillektomie). Available at: http://www.hno.at/fileadmin/hno/pdfs/Konsensuspapier_Tonsillekt omie_HNO_OEGKJ_9Nov2007.pdf (Accessed on: October 21, 2011).
63. Baugh RF, Archer SM, Mitchell RB, Rosenfeld RM, Amin R, Burns JJ, et al. Clinical practice guideline: Tonsillectomy in children. Otolaryngol Head Neck Surg 2011; 144(1 Suppl): S1-S30.
64. Paradise JL, Bluestone CD, Bachman RZ, Colborn DK, Bernard BS, Taylor FH, et al. Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials. N Engl J Med 1984; 310(11): 674-683.
65. Leroy M, Cabral H, Figueira M, Bouchet V, Huot H, Ram S, et al. Multiple consecutive lavage samplings reveal greater burden of disease and provide direct access to the nontypeable Haemophilus influenzae biofilm in experimental otitis media. Infect Immun 2007; 75(8): 4158-4172.
66. Toth, T. Anti-streptolysin O-latex reagent and process for its production. EP0089598 (1983).
67. Tanno, K., Iijima, H. Determination of anti-streptolysin O antibody. JP63298062 (1988).
68. Arai, K., Kagimoto, Y. Method for determining antistreptolysin O antibody. US5856202 (1999).
69. Toth, T. Latex agglutination method for the detection of an antibody against Streptococcus deoxyribonuclease B. EP0266686 (1988).
70. Soderholm, J. Serologic diagnostics of beta-streptococcal infections with the use of automatic reading with photometer for microtitra-tion plates. EP0170760 (1986).
71. Toth, T., Gils, R. Process for the determination of anti-hyaluronidase and an agent suitable for this purpose. US 4411988 (1983).
72. Tomiyama, T. Method for titration of anti-hyaluronidase antibody titer. JP01140067 (1989).
73. Podlasek, S. J., Mcpherson, R. A. Method for the detection of anti-streptokinase antibodies. EP19900909412 (1995).
74. Pizzo, S. V., Gonzalez-Gronow, M. C. B. A. Methods and agents for the diagnosis and treatment of rheumatoid arthritis. WO1994017411 (1994).
75. el-Kholy A, Hafez K, Krause RM. Specificity and sensitivity of the streptozyme test for the detection of streptococcal antibodies. Appl Microbiol 1974; 27(4): 748-752.
76. Mortimer GE, Widdowson JP. Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococ-cal M-associated protein. Clin Exp Immunol 1979; 37(2): 247-258.
77. Karmarkar MG, Venugopal V, Joshi L, Kamboj R. Evaluation & revaluation of upper limits of normal values of anti-streptolysin O & anti-deoxyribonuclease B in Mumbai. Indian J Med Res 2004; 119(Suppl): 26-28.
78. Kaplan EL, Rothermel CD, Johnson DR. Antistreptolysin O and anti-deoxyribonuclease B titers: Normal values for children ages 2 to 12 in the United States. Pediatrics 1998; 101(1 Pt 1): 86-88.
79. Sethi S, Kaushik K, Mohandas K, Sengupta C, Singh S, Sharma M. Anti-streptolysin O titers in normal healthy children of 5-15 years. Indian Pediatr 2003; 40(11): 1068-1071.
80. Dagnelie CF, Bartelink ML, van der Graaf Y, Goessens W, de Melker RA. Towards a better diagnosis of throat infections (with group A beta-haemolytic streptococcus) in general practice. Br J Gen Pract 1998;48(427):959-962.
81. Borschmann ME, Berkowitz RG. One-off streptococcal serologic testing in young children with recurrent tonsillitis. Ann Otol Rhinol Laryngol 2006; 115(5): 357-360.
82. Reichel O, Mayr D, Winterhoff J, de la Chaux R, Hagedorn H, Berghaus A. Tonsillotomy or tonsillectomy?--a prospective study comparing histological and immunological findings in recurrent tonsillitis and tonsillar hyperplasia. Eur Arch Otorhinolaryngol 2007; 264(3): 277-284.
83. Yokoyama Y, Harabuchi Y. Decreased serum and pharyngeal antibody levels specific to streptococcal lipoteichoic acid in children with recurrent tonsillitis. Int J Pediatr Otorhinolaryngol 2002; 63(3): 199-207.
84. López-González MA, Díaz P, Delgado F, Lucas M. Lack of lym-phoid cell apoptosis in the pathogenesis of tonsillar hypertrophy as compared to recurrent tonsillitis. Eur J Pediatr 1999; 158(6): 469-473.
85. Rosan B. The Streptococci. In: Newman MG, Nisengead R, Eds. Oral microbiology and immunology. Philadelphia: W.B. Saunders Co 1988: 145-166.
86. Huihua, D., Ling, L., Kecai, L. Chinese medicinal composition for treating tonsillitis. CN101843861 (2010).
87. Jiangtao, W., Xingtao, W., Yuehao, W., Yueying, X. Chinese medicinal preparation for treating canker sores and acute tonsillitis and preparation method thereof. CN101810642 (2010).
88. Lin, Z. Medicine for treating acute and chronic tonsillitis and preparation method thereof. CN101623391 (2010).
89. Sane, V. C. H. A. Method for an ayurvedic preparation for preventing and/or curing tonsillitis. IN185393 (2001).
90. Klosterfrau, M.C.M. Topical composition (in solid dosage form), useful to treat inflammatory diseases of mouth and throat e.g. tonsillitis, laryngitis, pharyngitis and gingivitis, comprises combination of Lichen islandicus and a local anesthetic. DE202004016077 (2005).
91. Klosterfrau, M.C.M. Solid dosage topical pharmaceutical composition, useful to treat inflammatory diseases of mouth and throat e.g. tonsillitis, laryngitis, pharyngitis, gingivitis and sore throat, comprises combination of viscous drug and a local anesthetic. DE202004016078 (2005).
92. Grahn, E. E., Holm, S. E. F. Pharmaceutical preparation in the treatment of tonsillitis. US5378459 (1995).
93. Welczer, A. Tonsillitis treatment. WO2008024715 (2008).
94. Weinrich, K. P., Kaplan, L. W. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea. US10443672 (2003).
95. Gozal, D. Method for treating snoring and sleep apnea with leukot-riene antagonists. WO2005027853 (2006).
96. Sclafani AP, Ginsburg J, Shah MK, Dolitsky JN. Treatment of symptomatic chronic adenotonsillar hypertrophy with amoxicil-lin/clavulanate potassium: Short- and long-term results. Pediatrics 1998; 101(4 Pt 1): 675-681.
97. Brook I. Medical treatment of non-streptococcal recurrent tonsillitis. Am J Otolaryngol 1989; 10(4): 227-233.
98. Orrling A, Stjernquist-Desatnik A, Schalén C. Clindamycin in recurrent group A streptococcal pharyngotonsillitis--an alternative to tonsillectomy? Acta Otolaryngol 1997; 117(4): 618-622.
99. Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D. Oral clindamycin 300 mg BID compared with oral amoxicil-lin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: An international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Clin Ther 2006; 28(1): 99-109.
100. Lemaire S, Kosowska-Shick K, Julian K, Tulkens PM, Van Bam-beke F, Appelbaum PC. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylo-coccus aureus isolates from a patient with persistent bacteraemia and endocarditis. Clin Microbiol Infect 2008; 14(8): 766-777.
101. Nguyen T, Louie SG, Beringer PM, Gill MA. Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease. Curr Opin Pulm Med 2002; 8(6): 521-528.
102. Swords WE, Rubin BK. Macrolide antibiotics, bacterial populations and inflammatory airway disease. Neth J Med 2003; 61(7): 242-248.
103. Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 1993; 37(9): 1749-1755.
104. Yasuda H, Ajiki Y, Koga T, Yokota T. Interaction between clarithromycin and biofilms formed by Staphylococcus epider-midis. Antimicrob Agents Chemother 1994; 3881: 138-141.
105. Harraghy N, Kerdudou S, Herrmann M. Quorum-sensing systems in Staphylococci as therapeutic targets. Anal Bioanal Chem 2007; 387(2): 437-444.
106. [Puymirat E, Biais M, Camou F, Lefèvre J, Guisset O, Gabinski V. A Lemierre syndrome variant caused by Staphylococcus aureus. Am J Emerg Med 2008; 26(3): 380.e5-7.
107. Karkos PD, Asrani S, Karkos CD, Leong SC, Theochari EG, Alexopoulou TD, et al. Lemierre's syndrome: A systematic review. Laryngoscope 2009; 119(8): 1552-1559.
108. Sazhin, A. V., Lvova, I. I. Method of chronic tonsillitis treatment. RU2357732 (2009).
109. Lotsmanov, J. A., Mareev, O. V., Djakonov, V. L., Zhigalov, V. A., Maltsev, M. V., Rogova, E. G. Method for treating chronic tonsillitis. RU2175565 (2001).
110. Darrow D, Siemens C. Indications for tonsillectomy and adenoi-dectomy. Laryngoscope 2002; 112(8 Pt 2 Suppl 100): 6-10.
111. Josephson, G. D. Adenoid curette. US6679897 (2004).
112. Anand A, Vilela RJ, Guarisco JL. Intracapsular versus standard tonsillectomy: Review of literature. J La State Med Soc 2005; 157(5): 259-261.
113. Gronau S, Fischer Y. Die Tonsillotomie. Laryngorhinootologie 2005; 84(9): 685-690.
114. [Österreichische Gesellschaft für Hals-Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie. Richtlinien für Mandeloperationen bei Kindern Tonsillektomie unter 6 Jahren soll die Ausnahme sein. Available at: http://www.docs4you.at/Content.Node/PresseCorner/ 2007/Neue_Richtlinien_fuer_Mandeloperationen.pdf (Accessed on: October 21, 2011).
115. Schmidt R, Herzog A, Cook S, O'Reilly R, Deutsch E, Reilly J. Complications of tonsillectomy: A comparison of techniques. Arch Otolaryngol Head Neck Surg 2007; 133(9): 925-928.
116. Hultcrantz E, Linder A, Markström A. Long-term effects of intra-capsular partial tonsillectomy (tonsillotomy) compared with full tonsillectomy. Int J Pediatr Otorhinolaryngol 2005; 69(4): 463-469.
117. Koltai PJ, Solares CA, Mascha EJ, Xu M. Intracapsular partial tonsillectomy for tonsillar hypertrophy in children. Laryngoscope 2002; 112(8 Pt 2 Suppl 100): 17-19.
118. Wolf M, Even-Chen I, Talmi YP, Kronenberg J. The indication for tonsillectomy in children following peritonsillar abscess. Int J Pe-diatr Otorhinolaryngol 1995; 31(1): 43-46.
119. Brojerdian S, Bisschop P. Clinical advantage of abscess tonsillec-tomy in peritonsillar abscess. Acta Otorhinolaryngol Belg 2000; 54(4): 459-464.
120. Jaffe BF. Different view on T and A. N Engl J Med 1972; 287(8): 414.
121. Terskova, N. V., Vakhrushev, S. G. Method of treating chronic adenoiditis and tonsillitis in children. RU2391108 (2010).
122. Khabarov, A. S., Zjablitskaja, N. K., Voloshchenko, L. G., Shojkhet, J. N. Method of chronic tonsillitis treatment in patients with immunodeficiency. RU2391991 (2010).
123. [Akulich II, Lopatin AS. Therapy of imudon after tonsillectomy. Vestn Otorinolaringol 2006; (6): 57-58.
124. Spisek R, Brazova J, Rozkova D, Zapletalova K, Sediva A, Bar-tunkova J. Maturation of dendritic cells by bacterial immunomodu-lators. Vaccine 2004; 22(21-22): 2761-2768.
125. Herrera D. Photodynamic therapy for chronic periodontitis. Evid Based Dent 2011; 12(3): 78-79.
126. Ofner JG, Bartl B, König S, Thumfart WF. Photodynamic therapy in selected cases at the ENT Clinic. J Photochem Photobiol B 1996; 36(2): 185-187.
127. Quon H, Finlay J, Cengel K, Zhu T, O'Malley B Jr, Weinstein G. Transoral robotic photodynamic therapy for the oropharynx. Pho-todiagnosis Photodyn Ther 2011; 8(1): 64-67
128. Ossoff R, Coleman JA, Courey MS, Duncavage JA, Werkhaven JA, Reinisch L. Clinical applications of lasers in otolaryngology-head and neck surgery. Lasers Surg Med 1994; 15(3): 217-248.
129. Zharov VP, Latyshev AS. Laser combined medical technologies from Russia. J Laser Appl 1999; 11(2): 80-90.
130. Chankov I. I., Khlusov, I. A. Method for treating chronic tonsillitis. RU2235568 (2004).
131. Pykhteeva, E. N., Reshetnikov, A. V., Zalevskij, I. D., Goncharov, S. E., Khamukova, O. S., Nesedkin, A. N., Ashchurov, Z. M., Gerasimenko, N. V., Inkina, A. V., Rusanova, E. V., Armichev, A. V., Zenger, V. G. Method of laser treatment of chronic tonsillitis with using photosensitiser. RU2379073 (2010).
132. Golovnev, A. V., Dergachev, V. S., Golovnev, V. A., Gorchakov, V. N. Method to model chronic tonsillitis. RU2180973 (2002).
133. Remacle M, Keghian J, Lawson G, Jamart J. Carbon-dioxide laser-assisted tonsil ablation for adults with chronic tonsillitis: A 6-month follow-up study. Eur Arch Otorhinolaryngol 2003; 26088: 456-459.
134. Davenport, S.A., Murray, S.C., Coleman, T.D., Garlich, H., Arnold, K., Nahen, K. Surgical apparatus for laser ablation of soft tissue. US11614265 (2006).
135. Hovda, D.C., Ellsberry, M.B., Eggers, P.E. Thapliyal, H.V. Systems and methods for electrosurgical sinus surgery. US6053172 (1998).
136. Lau, L., Escano, A.M., Jarrard, J., Ho, S., Abbott, R.C., Lin, A.M., McQuiston, J., Callas, P.L., Willis, G.H., Stewart, M.C., Barkman, K.D., Lamberti, J.N., Dang, K.L. Tissue welding and cutting apparatus and method. US11090750 (2005).